5 Best European Dividend Stocks to Buy

4. GSK Plc (NYSE:GSK)

Number of Hedge Fund Investors: 52

UK-based pharma giant GSK Plc (NYSE:GSK) has a dividend yield of about 3.8% as of December 16.

A total of 52 hedge funds tracked by Insider Monkey had stakes in GSK Plc (NYSE:GSK) as of the end of September.

Ariel Global Fund made the following comment about GSK plc (NYSE:GSK) in its Q3 2023 investor letter:

“Global pharmaceutical and healthcare company, GSK plc (NYSE:GSK), also advanced in the period following a top- and bottom-line earnings beat and subsequent raise in full-year guidance. Shares were also aided by a successful U.S. and European launch of Arexvy, a respiratory syncytial virus (RSV) vaccine for older adults. Although risks around the Zantac litigation remain a concern, we believe GSK should generate sustainable growth and margin expansion as the company transitions its Pharma pipeline towards specialty medicines and vaccines. Furthermore, the company’s robust balance sheet provides the scope for bolt-ons, which has the potential to drive additional growth.”